Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fully Automated Lyumjev-Pramlintide Delivery in T1D
NCT06046417Phase 3Recruiting
- Sponsor
- McGill University Health Centre
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pramlintide in type 1 diabetes mellitus (T1D), sponsored by McGill University Health Centre. Started Nov 2023; status: recruiting.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06046417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046417.